ASN
WVE icon

Advisory Services Network’s Wave Life Sciences WVE Stock Holding History

Advisory Services Network’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
144,950
+124,050
+594% +$1.62M 0.01% 912
2025
Q4 		$355K Buy
+20,900
New +$212K 0.01% 1392

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Advisory Services Network's WVE Position: Q1 2026 in Review

Advisory Services Network increased its Wave Life Sciences (WVE) stake by 594% in Q1 2026, buying an estimated $1.62M and bringing the position to 144,950 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #912.

Advisory Services Network first reported a position in WVE in Q4 2025 and has held it in 2 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Advisory Services Network held 144,950 shares of Wave Life Sciences worth $1.05M as of Q1 2026.
  • Advisory Services Network bought 124,050 Wave Life Sciences shares in Q1 2026, an estimated $1.62M.
  • Wave Life Sciences made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #912 holding.
  • Advisory Services Network first reported a position in Wave Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.